Literature DB >> 30288221

Development of subnanomolar-affinity serotonin 5-HT4 receptor ligands based on quinoline structures.

Federica Castriconi1, Marco Paolino1, Giorgio Grisci1, Cinzia Maria Francini1, Annalisa Reale1, Germano Giuliani1, Maurizio Anzini1, Gianluca Giorgi1, Laura Mennuni2, Chiara Sabatini2, Marco Lanza2, Gianfranco Caselli2, Andrea Cappelli1.   

Abstract

Two small series of quinoline derivatives were designed starting from previously published quinoline derivatives 7a and b in order to obtain information about their interaction with the 5-HT4R binding site. Initially, the structure of 7a and b was modified by replacing their basic moiety with that of partial agonist 4 (ML10302) or with that of reference ligand 6 (RS-67-333). Then, the aromatic moieties of 4-quinolinecarboxylates 7a, d-f, and h-k or 4-quinolinecarboxamides 7b, c, and g were modified into those of 2-quinolinecarboxamides 9a-e. Very interestingly, this structure-affinity relationship study led to the discovery of 7h-j as novel 5-HT4R ligands showing K i values in the subnanomolar range. The structures of all these compounds contain the N-butyl-4-piperidinylmethyl substituent, which appear to behave as an optimized basic moiety in the interaction of these 4-quinolinecarboxylates with the 5-HT4R binding site. However, this basic moiety was ineffective in providing 5-HT4R affinity in the corresponding 4-quinolinecarboxamide 7g, but it did in 2-quinolinecarboxamide ligands 9c-e. Thus, a subtle interrelationship of several structural parameters appeared to play a major role in the interaction of the ligands with the 5-HT4R binding site. They include the kind of basic moiety, the position of the carbonyl linking group with respect to the aromatic moiety and its orientation, which could be affected by the presence of the intramolecular H-bond as in compounds 9c-e.

Entities:  

Year:  2018        PMID: 30288221      PMCID: PMC6148519          DOI: 10.1039/c8md00233a

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  18 in total

Review 1.  5-HT(4) receptors: history, molecular pharmacology and brain functions.

Authors:  Joël Bockaert; Sylvie Claeysen; Valérie Compan; Aline Dumuis
Journal:  Neuropharmacology       Date:  2008-05-23       Impact factor: 5.250

2.  Identification of multiple 5-HT₄ partial agonist clinical candidates for the treatment of Alzheimer's disease.

Authors:  Michael A Brodney; David E Johnson; Aarti Sawant-Basak; Karen J Coffman; Elena M Drummond; Emily L Hudson; Katherine E Fisher; Hirohide Noguchi; Nobuaki Waizumi; Laura L McDowell; Alexandros Papanikolaou; Betty A Pettersen; Anne W Schmidt; Elaine Tseng; Kim Stutzman-Engwall; David M Rubitski; Michelle A Vanase-Frawley; Sarah Grimwood
Journal:  J Med Chem       Date:  2012-10-05       Impact factor: 7.446

3.  Dendrimeric tetravalent ligands for the serotonin-gated ion channel.

Authors:  Marco Paolino; Laura Mennuni; Germano Giuliani; Maurizio Anzini; Marco Lanza; Gianfranco Caselli; Chiara Galimberti; Maria Cristina Menziani; Alessandro Donati; Andrea Cappelli
Journal:  Chem Commun (Camb)       Date:  2014-06-23       Impact factor: 6.222

4.  5-HT(4) receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: A pharmacodynamic and pharmacokinetic assessment.

Authors:  Fei Shen; Jacqueline A M Smith; Ray Chang; David L Bourdet; Pamela R Tsuruda; Glenmar P Obedencio; David T Beattie
Journal:  Neuropharmacology       Date:  2011-03-12       Impact factor: 5.250

5.  The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons.

Authors:  A Dumuis; M Sebben; J Bockaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

6.  Development of a radioligand binding assay for 5-HT4 receptors in guinea-pig and rat brain.

Authors:  C J Grossman; G J Kilpatrick; K T Bunce
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

Review 7.  Molecular biology of 5-HT receptors.

Authors:  Jason Hannon; Daniel Hoyer
Journal:  Behav Brain Res       Date:  2008-03-25       Impact factor: 3.332

Review 8.  The Interactions of the 5-HT(3) receptor with arylpiperazine, tropane, and quinuclidine ligands.

Authors:  Andrea Cappelli; Maurizio Anzini; Salvatore Vomero; Laura Mennuni; Francesco Makovec; Michel Hamon; Pier G De Benedetti; M Cristina Menziani
Journal:  Curr Top Med Chem       Date:  2002-06       Impact factor: 3.295

9.  2-aroylindoles and 2-aroylbenzofurans with N-hydroxyacrylamide substructures as a novel series of rationally designed histone deacetylase inhibitors.

Authors:  Siavosh Mahboobi; Andreas Sellmer; Heymo Höcher; Christian Garhammer; Herwig Pongratz; Thomas Maier; Thomas Ciossek; Thomas Beckers
Journal:  J Med Chem       Date:  2007-08-11       Impact factor: 7.446

10.  Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds.

Authors:  Andrea Cappelli; Monica Manini; Salvatore Valenti; Federica Castriconi; Germano Giuliani; Maurizio Anzini; Simone Brogi; Stefania Butini; Sandra Gemma; Giuseppe Campiani; Gianluca Giorgi; Laura Mennuni; Marco Lanza; Antonio Giordani; Gianfranco Caselli; Ornella Letari; Francesco Makovec
Journal:  Eur J Med Chem       Date:  2013-02-08       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.